AVITA Medical (RCEL) News Today $9.38 +0.06 (+0.64%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period AVITA Medical’s SWOT analysis: regenerative medicine stock faces growth hurdlesMarch 21, 2025 | uk.investing.comAVITA Medical (NASDAQ:RCEL) Earns Buy Rating from D. Boral CapitalD. Boral Capital reissued a "buy" rating and issued a $22.00 target price on shares of AVITA Medical in a research report on Tuesday.March 19, 2025 | marketbeat.comAVITA Medical's (RCEL) Buy Rating Reaffirmed at D. Boral CapitalMarch 19, 2025 | americanbankingnews.com4RCEL : What Analysts Are Saying About AVITA Medical StockMarch 18, 2025 | benzinga.comAvita Medical amends PermeaDerm distribution agreement with Stedical ScientificMarch 17, 2025 | markets.businessinsider.comAvita Medical Boosts Production with New AgreementMarch 17, 2025 | tipranks.comAVITA Medical Announces Exclusive Manufacturing and Distribution Agreements with Stedical ScientificMarch 17, 2025 | globenewswire.comDoes Avita Medical (RCEL) Have the Potential to Rally 73.72% as Wall Street Analysts Expect?March 13, 2025 | msn.comAvita Medical management to meet with Lake StreetFebruary 27, 2025 | markets.businessinsider.comAVITA Medical to Present at TD Cowen's 45ᵗʰ Annual Health Care ConferenceFebruary 26, 2025 | globenewswire.comAVITA Medical, Inc. (NASDAQ:RCEL) Director Robert Mcnamara Purchases 10,000 SharesAVITA Medical, Inc. (NASDAQ:RCEL - Get Free Report) Director Robert Mcnamara acquired 10,000 shares of the stock in a transaction that occurred on Thursday, February 20th. The stock was purchased at an average cost of $10.09 per share, with a total value of $100,900.00. Following the completion of the acquisition, the director now owns 45,749 shares of the company's stock, valued at $461,607.41. The trade was a 27.97 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.February 21, 2025 | marketbeat.comD. Boral Capital Has Lowered Expectations for AVITA Medical (NASDAQ:RCEL) Stock PriceD. Boral Capital lowered their price target on AVITA Medical from $25.00 to $22.00 and set a "buy" rating for the company in a research report on Thursday.February 21, 2025 | marketbeat.comAVITA Medical, Inc. (NASDAQ:RCEL) CFO Purchases $10,250.00 in StockAVITA Medical, Inc. (NASDAQ:RCEL - Get Free Report) CFO David D. O'toole bought 1,000 shares of AVITA Medical stock in a transaction on Wednesday, February 19th. The stock was acquired at an average price of $10.25 per share, for a total transaction of $10,250.00. Following the purchase, the chief financial officer now owns 24,734 shares of the company's stock, valued at approximately $253,523.50. This trade represents a 4.21 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.February 20, 2025 | marketbeat.comAvita Medical price target lowered to $22 from $25 at D. Boral CapitalFebruary 20, 2025 | markets.businessinsider.comAVITA Medical, Inc. (RCEL): A Bull Case TheoryFebruary 20, 2025 | insidermonkey.comDavid D. O'toole Buys 1,000 Shares of AVITA Medical, Inc. (NASDAQ:RCEL) StockFebruary 20, 2025 | insidertrades.comAVITA Medical (RCEL) Expected to Announce Earnings on ThursdayAVITA Medical (NASDAQ:RCEL) will be releasing earnings after the market closes on Thursday, February 27. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=655168)February 20, 2025 | marketbeat.comAfter Sales Rebound In January, AVITA Is Set Up For A Monster YearFebruary 18, 2025 | seekingalpha.comAVITA Medical's (RCEL) Buy Rating Reiterated at D. Boral CapitalD. Boral Capital reiterated a "buy" rating and issued a $25.00 target price on shares of AVITA Medical in a research note on Friday.February 15, 2025 | marketbeat.comAvita Medical price target lowered to $11 from $12 at Piper SandlerFebruary 15, 2025 | markets.businessinsider.comAVITA Medical (NASDAQ:RCEL) Posts Earnings Results, Misses Estimates By $0.14 EPSAVITA Medical (NASDAQ:RCEL - Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.44) EPS for the quarter, missing the consensus estimate of ($0.30) by ($0.14). AVITA Medical had a negative net margin of 95.47% and a negative return on equity of 194.69%.February 14, 2025 | marketbeat.comAVITA Medical to Host Investor Webinar BriefingFebruary 14, 2025 | globenewswire.comAVITA Medical, Inc. (RCEL) Q4 2024 Earnings Call TranscriptFebruary 13, 2025 | seekingalpha.comAVITA Medical Reports Fourth Quarter and Full Year 2024 Financial ResultsFebruary 13, 2025 | globenewswire.comCantor Fitzgerald Estimates AVITA Medical FY2024 EarningsAVITA Medical, Inc. (NASDAQ:RCEL - Free Report) - Stock analysts at Cantor Fitzgerald decreased their FY2024 EPS estimates for shares of AVITA Medical in a report released on Tuesday, January 21st. Cantor Fitzgerald analyst R. Osborn now anticipates that the company will earn ($2.51) per share foJanuary 23, 2025 | marketbeat.comCantor Fitzgerald Forecasts AVITA Medical FY2025 EarningsAVITA Medical, Inc. (NASDAQ:RCEL - Free Report) - Equities research analysts at Cantor Fitzgerald issued their FY2025 earnings per share estimates for shares of AVITA Medical in a research report issued on Tuesday, January 21st. Cantor Fitzgerald analyst R. Osborn anticipates that the company wilJanuary 22, 2025 | marketbeat.comAVITA Medical, Inc. (NASDAQ:RCEL) Holdings Boosted by Barclays PLCBarclays PLC grew its stake in shares of AVITA Medical, Inc. (NASDAQ:RCEL - Free Report) by 340.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 37,503 shares of the company's stock after purchasing an additional 28,979January 19, 2025 | marketbeat.comShort Interest in AVITA Medical, Inc. (NASDAQ:RCEL) Rises By 25.9%AVITA Medical, Inc. (NASDAQ:RCEL - Get Free Report) was the recipient of a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 1,460,000 shares, an increase of 25.9% from the December 15th total of 1,160,000 shares. Currently, 5.9% of the company's shares are short sold. Based on an average daily volume of 132,500 shares, the short-interest ratio is currently 11.0 days.January 18, 2025 | marketbeat.comInvestors Burned By AVITA Medical's Sales Miss: I'm Even More BullishJanuary 12, 2025 | seekingalpha.comAVITA Medical: A Dip Buy As 2025 Looks Bullish With Cohealyx And RECELL GO MiniJanuary 10, 2025 | seekingalpha.comAvita Medical price target lowered to $14 from $20 at Lake StreetJanuary 10, 2025 | markets.businessinsider.comAVITA Medical, Inc. (RCEL): A Bull Case TheoryJanuary 9, 2025 | insidermonkey.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: CAMP4 Therapeutics Corporation (CAMP) and Avita Medical (RCEL)January 8, 2025 | markets.businessinsider.comCantor Fitzgerald Sticks to Its Buy Rating for Avita Medical (RCEL)January 8, 2025 | markets.businessinsider.comAvita Medical Cuts Annual Sales Forecast On Softer Demand From HospitalsJanuary 8, 2025 | benzinga.comAVITA Medical (NASDAQ:RCEL) Price Target Cut to $14.00 by Analysts at Lake Street CapitalLake Street Capital reduced their price objective on shares of AVITA Medical from $20.00 to $14.00 and set a "buy" rating on the stock in a research note on Wednesday.January 8, 2025 | marketbeat.comAVITA Medical (NASDAQ:RCEL) Receives "Buy" Rating from D. Boral CapitalD. Boral Capital restated a "buy" rating and set a $25.00 price objective on shares of AVITA Medical in a research report on Wednesday.January 8, 2025 | marketbeat.comAVITA Medical stock slides 14% on lowered guidanceJanuary 8, 2025 | msn.comAVITA Medical's shares sink 19% after another forecast cutJanuary 7, 2025 | reuters.comAVITA Medical Updates Expected Fourth Quarter and Full Year 2024 Revenue, Provides 2025 Financial GuidanceJanuary 7, 2025 | globenewswire.comAVITA Medical Just Tripled Its TAM In The Burn MarketJanuary 2, 2025 | seekingalpha.comCantor Fitzgerald bullish on Avita Medical after FDA approval for RECELL GO MiniDecember 25, 2024 | finance.yahoo.comAvita Medical initiated with a Buy at D. Boral CapitalDecember 25, 2024 | markets.businessinsider.comLake Street Reaffirms Their Buy Rating on Avita Medical (RCEL)December 25, 2024 | markets.businessinsider.comD. Boral Capital Initiates Coverage of AVITA Medical (RCEL) with Buy RecommendationDecember 25, 2024 | msn.comAVITA Medical (NASDAQ:RCEL) Stock Quotes, Forecast and News SummaryDecember 24, 2024 | benzinga.comCantor Fitzgerald Reiterates "Overweight" Rating for AVITA Medical (NASDAQ:RCEL)Cantor Fitzgerald restated an "overweight" rating and issued a $21.00 price objective on shares of AVITA Medical in a report on Tuesday.December 24, 2024 | marketbeat.comAVITA Medical (NASDAQ:RCEL) Earns Buy Rating from Analysts at D. Boral CapitalD. Boral Capital began coverage on AVITA Medical in a research report on Tuesday. They set a "buy" rating and a $25.00 price target on the stock.December 24, 2024 | marketbeat.comAvita Medical discloses FDA premarket approval for ECELL GO miniDecember 24, 2024 | markets.businessinsider.comAvita gets FDA approval for RECELL GO miniDecember 24, 2024 | msn.com Remove Ads Get AVITA Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for RCEL and its competitors with MarketBeat's FREE daily newsletter. Email Address RCEL Media Mentions By Week RCEL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RCEL News Sentiment▼0.270.62▲Average Medical News Sentiment RCEL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RCEL Articles This Week▼32▲RCEL Articles Average Week Remove Ads Get AVITA Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for RCEL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AxoGen News Bioventus News CeriBell News Embecta News Butterfly Network News Iradimed News Avanos Medical News Beta Bionics News SI-BONE News OrthoPediatrics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RCEL) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AVITA Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AVITA Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RCEL Stock Free RCEL Stock Alerts